GAITHERSBURG, Md., March 1 (Reuters) - A U.S. advisory panel rejected a Medtronic Inc. (MDT.N: Quote, Profile , Research) implanted heart monitor on Thursday after concluding the company failed to show its use would lead to fewer hospitalizations from heart failure.
